Role of adipose-derived stem cells in wound healing

Wound Repair and Regeneration

Volumn 22, Issue 3, 2014, Pages 313-325

  Hassan, Waqar Ul ^a   Greiser, Udo ^a   Wang, Wenxin ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR;

ADIPOSE DERIVED STEM CELL; ADIPOSE TISSUE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; CHRONIC WOUND; CLINICAL TRIAL (TOPIC); DIABETIC FOOT; ENDOTHELIAL PROGENITOR CELL; HUMAN; HYPOXIA; KERATINOCYTE; MESENCHYMAL STEM CELL; NONHUMAN; PARACRINE SIGNALING; PATHOGENESIS; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; SAFETY; SKIN FIBROBLAST; STEM CELL TRANSPLANTATION; TISSUE REGENERATION; WOUND HEALING; WOUND HEALING IMPAIRMENT; ADIPOCYTE; CHRONIC DISEASE; IMMUNOLOGY; METABOLISM; PATHOLOGY; REGENERATION; SKIN; TISSUE ENGINEERING; TRANSPLANTATION; WOUNDS AND INJURIES;

ADIPOCYTES; ADIPOSE TISSUE; CHRONIC DISEASE; HUMANS; PLURIPOTENT STEM CELLS; REGENERATION; SKIN; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING; WOUND HEALING; WOUNDS AND INJURIES;

EID: 84901004307     PISSN: 10671927     EISSN: 1524475X     Source Type: Journal    
DOI: 10.1111/wrr.12173     Document Type: Review

References (151)

1. Williams PL, Bannister LH, Berry MM, Collins P, Dyson M, Dussek JE,. Gray's anatomy international student edition, 38th ed. Oxford: Churchill Livingstone, 1995.
2. Atiyeh BS, Ioannovich J, Al-Amm CA, El-Musa KA,. Management of acute and chronic open wounds: the importance of moist environment in optimal wound healing. Curr Pharm Biotechnol 2002; 3: 179-195.
3. Lazarus GS, Cooper DM, Knighton DR, Percoraro RE, Rodeheaver G, Robson MC,. Definitions and guidelines for assessment of wounds and evaluation of healing. Wound Repair Regen 1994; 2: 165-170.
4. Vileikyte L,. Diabetic foot ulcers: a quality of life issue. Diabetes Metab Res Rev 2001; 17: 246-249.
5. Crovetti G, Martinelli G, Issi M, Barone M, Guizzardi M, Campanati B, etal. Platelet gel for healing cutaneous chronic wounds. Transfus Apher Sci 2004; 30: 145-151.
6. Simka M, Majewski E,. The social and economic burden of venous leg ulcers-focus on the role of micronized purified flavonoid fraction adjuvant therapy. Am J Clin Dermatol 2003; 4: 573-581.
7. Braddock M, Campbell CJ, Zuder D,. Current therapies for wound healing: electrical stimulation, biological therapeutics, and the potential for gene therapy. Int J Dermatol 1999; 38: 808-817.
8. Mustoe TA, O'Shaughnessy K, Kloeters O,. Chronic wound pathogenesis and current treatment strategies: a unifying hypothesis. Plast Reconstr Surg 2006; 117: 35s-41s.
9. Phillips TJ,. Current approaches to venous ulcers and compression. Dermatol Surg 2001; 27: 611-621.
10. Beckrich K, Aronovitch SA,. Hospital-acquired pressure ulcers: a comparison of costs in medical versus surgical patients. Nurs Econ 1999; 17: 263-271.
11. Boyce ST, Warden GD,. Principles and practices for treatment of cutaneous wounds with cultured skin substitutes. Am J Surg 2002; 183: 445-456.
12. Falanga V,. Advanced treatments for non-healing chronic wounds. EWMA J 2004; 4: 11-13.
13. Mimeault M, Hauke R, Batra S,. Stem cells: a revolution in therapeutics-recent advances in stem cell biology and their therapeutic applications in regenerative medicine and cancer therapies. Clin Pharmacol Therap 2007; 82: 252-264.
14. Körbling M, Estrov Z,. Adult stem cells for tissue repair-a new therapeutic concept? N Engl J Med 2003; 349: 570-582.
15. Strauer BE, Kornowski R,. Stem cell therapy in perspective. Circulation 2003; 107: 929-934.
16. Griffith LG, Naughton G,. Tissue engineering-current challenges and expanding opportunities. Science 2002; 295: 1009.
17. Parker AM, Katz AJ,. Adipose-derived stem cells for the regeneration of damaged tissues. Expert Opinion on Biological Therapy 2006; 6: 567-578.
18. Barry FP, Murphy JM,. Mesenchymal stem cells: clinical applications and biological characterization. Int J Biochem Cell Biol 2004; 36: 568-584.
19. Bianco P, Riminucci M, Gronthos S, Robey PG,. Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells 2001; 19: 180-192.
20. Bianco P, Robey PG,. Stem cells in tissue engineering. Nature 2001; 414: 118-121.
21. Pittenger MF, Martin BJ,. Mesenchymal stem cells and their potential as cardiac therapeutics. Circ Res 2004; 95: 9-20.
22. Levenberg S, Khademhosseini A, Langer R,. Embryonic stem cells in tissue engineering. Methods Tissue Eng 2002; 457.
23. Smith AG,. Embryo-derived stem cells: of mice and men. Annu Rev Cell Dev Biol 2001; 17: 435-462.
24. Takahashi K, Yamanaka S,. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126: 663-676.
25. Park I-H, Arora N, Huo H, Maherali N, Ahfeldt T, Shimamura A, etal. Disease-specific induced pluripotent stem cells. Cell 2008; 134: 877-886.
26. Gronthos S, Franklin DM, Leddy HA, Robey PG, Storms RW, Gimble JM,. Surface protein characterization of human adipose tissue-derived stromal cells. J Cell Physiol 2001; 189: 54-63.
27. Musina R, Bekchanova E, Sukhikh G,. Comparison of mesenchymal stem cells obtained from different human tissues. Bull Exp Biol Med 2005; 139: 504-509.
28. Sakaguchi Y, Sekiya I, Yagishita K, Muneta T,. Comparison of human stem cells derived from various mesenchymal tissues: superiority of synovium as a cell source. Arthritis Rheum 2005; 52: 2521-2529.
29. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, etal. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143-147.
30. Katz AJ, Tholpady A, Tholpady SS, Shang H, Ogle RC,. Cell surface and transcriptional characterization of human adipose-derived adherent stromal (hADAS) cells. Stem Cells 2005; 23: 412-423.
31. Winter A, Breit S, Parsch D, Benz K, Steck E, Hauner H, etal. Cartilage-like gene expression in differentiated human stem cell spheroids: a comparison of bone marrow-derived and adipose tissue-derived stromal cells. Arthritis Rheum 2003; 48: 418-429.
32. Liu TM, Martina M, Hutmacher DW, Hui JHP, Lee EH, Lim B,. Identification of common pathways mediating differentiation of bone marrow-and adipose tissue-derived human mesenchymal stem cells into three mesenchymal lineages. Stem Cells 2007; 25: 750-760.
33. Fraser JK, Wulur I, Alfonso Z, Hedrick MH,. Fat tissue: an underappreciated source of stem cells for biotechnology. Trends Biotechnol 2006; 24: 150-154.
34. Gosain A, DiPietro LA,. Aging and wound healing. World J Surg 2004; 28: 321-326.
35. Guo S, DiPietro LA,. Factors affecting wound healing. J Dent Res 2010; 89: 219-229.
36. Menke NB, Ward KR, Witten TM, Bonchev DG, Diegelmann RF,. Impaired wound healing. Clin Dermatol 2007; 25: 19-25.
37. Mulder GD, Vande Berg JS,. Cellular senescence and matrix metalloproteinase activity in chronic wounds: relevance to debridement and new technologies. J Am Podiatr Med Assoc 2002; 92: 34-37.
38. Diegelmann RF, Evans MC,. Wound healing: an overview of acute, fibrotic and delayed healing. Front Biosci 2004; 9: 283-289.
39. Mathieu D,. Handbook of hyperbaric medicine. New York: Springer, 2006: 812.
40. Singer AJ, Dagum AB,. Current management of acute cutaneous wounds. N Engl J Med 2008; 359: 1037-1046.
41. Marler JJ, Upton J, Langer R, Vacanti JP,. Transplantation of cells in matrices for tissue regeneration. Adv Drug Del Rev 1998; 33: 165-182.
42. Huss FR, Nyman E, Gustafson C-J, Gisselfält K, Liljensten E, Kratz G,. Characterization of a new degradable polymer scaffold for regeneration of the dermis: in vitro and in vivo human studies. Organogenesis 2008; 4: 195-200.
43. MacNeil S,. Progress and opportunities for tissue-engineered skin. Nature 2007; 445: 874-880.
44. Compton CC, Hickerson W, Nadire K, Press W,. Acceleration of skin regeneration from cultured epithelial autografts by transplantation to homograft dermis. J Burn Care Rehabil 1993; 14: 653-662.
45. Burke JF, Yannas IV, Quinby WC Jr, Bondoc CC, Jung WK,. Successful use of a physiologically acceptable artificial skin in the treatment of extensive burn injury. Ann Surg 1981; 194: 413-428.
46. Sun G, Zhang X, Shen Y-I, Sebastian R, Dickinson LE, Fox-Talbot K, etal. Dextran hydrogel scaffolds enhance angiogenic responses and promote complete skin regeneration during burn wound healing. Proc Natl Acad Sci 2011; 108: 20976-20981.
47. Kawai K, Suzuki S, Tabata Y, Ikada Y, Nishimura Y,. Accelerated tissue regeneration through incorporation of basic fibroblast growth factor-impregnated gelatin microspheres into artificial dermis. Biomaterials 2000; 21: 489-499.
48. Cornwell KG, Landsman A, James KS,. Extracellular matrix biomaterials for soft tissue repair. Clin Podiatr Med Surg 2009; 26: 507-523.
49. Gohari S, Gambla C, Healey M, Spaulding G, Gordon KB, Swan J, etal. Evaluation of tissue-engineered skin (human skin substitute) and secondary intention healing in the treatment of full thickness wounds after Mohs micrographic or excisional surgery. Dermatol Surg 2002; 28: 1107-1114.
50. Lattari V, Jones LM, Varcelotti JR, Latenser BA, Sherman HF, Barrette RR,. The use of a permanent dermal allograft in full-thickness burns of the hand and foot: a report of three cases. J Burn Care Rehabil 1997; 18: 147-155.
51. Wainwright D, Madden M, Luterman A, Hunt J, Monafo W, Heimbach D, etal. Clinical evaluation of an acellular allograft dermal matrix in full-thickness burns. J Burn Care Rehabil 1996; 17: 124-136.
52. Beumer GJ, van Blitterswijk CA, Ponec M,. Biocompatibility of a biodegradable matrix used as a skin substitute: an in vivo evaluation. J Biomed Mat Res 1994; 28: 545-552.
53. Branski LK, Herndon DN, Pereira C, Mlcak RP, Celis MM, Lee JO, etal. Longitudinal assessment of Integra in primary burn management: a randomized pediatric clinical trial. Crit Care Med 2007; 35: 2615-2623.
54. Lu D, Chen B, Liang Z, Deng W, Jiang Y, Li S, etal. Comparison of bone marrow mesenchymal stem cells with bone marrow-derived mononuclear cells for treatment of diabetic critical limb ischemia and foot ulcer: a double-blind, randomized, controlled trial. Diabetes Res Clin Pract 2011; 92: 26-36.
55. Lenk K, Adams V, Lurz P, Erbs S, Linke A, Gielen S, etal. Therapeutical potential of blood-derived progenitor cells in patients with peripheral arterial occlusive disease and critical limb ischaemia. Eur Heart J 2005; 26: 1903-1909.
56. Procházka V, Gumulec J, Jaluvka F, Salounová D, Jonszta T, Czerny D, etal. Cell therapy, a new standard in management of chronic critical limb ischemia and foot ulcer. Cell Transplant 2010; 19: 1413-1424.
57. Barcelos LS, Duplaa C, Kränkel N, Graiani G, Invernici G, Katare R, etal. Human CD133+ progenitor cells promote the healing of diabetic ischemic ulcers by paracrine stimulation of angiogenesis and activation of Wnt signaling. Circ Res 2009; 104: 1095-1102.
58. Kirana S, Stratmann B, Lammers D, Negrean M, Stirban A, Minartz P, etal. Wound therapy with autologous bone marrow stem cells in diabetic patients with ischaemia-induced tissue ulcers affecting the lower limbs. Int J Clin Pract 2007; 61: 690-694.
59. Hanson SE, Kleinbeck KR, Cantu D, Kim J, Bentz ML, Faucher LD, etal. Local delivery of allogeneic bone marrow and adipose tissue-derived mesenchymal stromal cells for cutaneous wound healing in a porcine model. J Tissue Eng Regen Med 2013 Feb 18 [Epub ahead of print].
60. Aranguren XL, Verfaillie CM, Luttun A,. Emerging hurdles in stem cell therapy for peripheral vascular disease. J Mol Med (Berl) 2009; 87: 3-16.
61. Yoshikawa T, Mitsuno H, Nonaka I, Sen Y, Kawanishi K, Inada Y, etal. Wound therapy by marrow mesenchymal cell transplantation. Plast Reconstr Surg 2008; 121: 860-877.
62. Vojtassak J, Danisovic L, Kubes M,. Autologous bio-graft and mesenchymal stem cells in treatment of the diabetic foot. Neuro Endocrinol Lett 2006; 27 (Suppl. 2): 134-137.
63. Gonda K, Shigeura T, Sato T, Matsumoto D, Suga H, Inoue K, etal. Preserved proliferative capacity and multipotency of human adipose-derived stem cells after long-term cryopreservation. Plast Reconstr Surg 2008; 121: 401-410.
64. Chung HM, Won CH, Sung JH,. Responses of adipose-derived stem cells during hypoxia: enhanced skin-regenerative potential. Expert Opin Biol Ther 2009; 9: 1499-1508.
65. Kakudo N, Minakata T, Mitsui T, Kushida S, Notodihardjo FZ, Kusumoto K,. Proliferation-promoting effect of platelet-rich plasma on human adipose-derived stem cells and human dermal fibroblasts. Plast Reconstr Surg 2008; 122: 1352-1360.
66. Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, etal. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 2001; 7: 211-228.
67. Schipper BM, Marra KG, Zhang W, Donnenberg AD, Rubin JP,. Regional anatomic and age effects on cell function of human adipose-derived stem cells. Ann Plast Surg 2008; 60: 538-544.
68. Anderson DJ, Gage FH, Weissman IL,. Can stem cells cross lineage boundaries? Nat Med 2001; 7: 393-395.
69. Kim W-S, Park B-S, Sung J-H, Yang J-M, Park S-B, Kwak S-J, etal. Wound healing effect of adipose-derived stem cells: a critical role of secretory factors on human dermal fibroblasts. J Dermatol Sci 2007; 48: 15-24.
70. van der Veen VC, van der Wal M, van Leeuwen MC, Ulrich MM, Middelkoop E,. Biological background of dermal substitutes. Burns 2010; 36: 305-321.
71. Nie C, Yang D, Morris SF,. Local delivery of adipose-derived stem cells via acellular dermal matrix as a scaffold: a new promising strategy to accelerate wound healing. Med Hypotheses 2009; 72: 679-682.
72. Hong SJ, Jia S-X, Xie P, Xu W, Leung KP, Mustoe TA, etal. Topically delivered adipose derived stem cells show an activated-fibroblast phenotype and enhance granulation tissue formation in skin wounds. PLoS ONE 2013; 8: e55640.
73. Cui L, Yin S, Liu W, Li N, Zhang W, Cao Y,. Expanded adipose-derived stem cells suppress mixed lymphocyte reaction by secretion of prostaglandin E2. Tissue Eng 2007; 13: 1185-1195.
74. Puissant B, Barreau C, Bourin P, Clavel C, Corre J, Bousquet C, etal. Immunomodulatory effect of human adipose tissue-derived adult stem cells: comparison with bone marrow mesenchymal stem cells. Br J Haematol 2005; 129: 118-129.
75. Gnecchi M, Zhang Z, Ni A, Dzau VJ,. Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res 2008; 103: 1204-1219.
76. Ebrahimian T, Pouzoulet F, Squiban C, Buard V, André M, Cousin B, etal. Cell therapy based on adipose tissue-derived stromal cells promotes physiological and pathological wound healing. Arterioscler Thromb Vasc Biol 2009; 29: 503-510.
77. Cai L, Johnstone BH, Cook TG, Tan J, Fishbein MC, Chen PS, etal. IFATS collection: human adipose tissue-derived stem cells induce angiogenesis and nerve sprouting following myocardial infarction, in conjunction with potent preservation of cardiac function. Stem Cells 2009; 27: 230-237.
78. Rehman J, Traktuev D, Li J, Merfeld-Clauss S, Temm-Grove CJ, Bovenkerk JE, etal. Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation 2004; 109: 1292-1298.
79. Hass R, Kasper C, Bohm S, Jacobs R,. Different populations and sources of human mesenchymal stem cells (MSC): a comparison of adult and neonatal tissue-derived MSC. Cell Commun Signal 2011; 9: 12.
80. Yoshimura K, Suga H, Eto H,. Adipose-derived stem/progenitor cells: roles in adipose tissue remodeling and potential use for soft tissue augmentation. Regen Med 2009; 4: 265-273.
81. Bernardo E, Locatelli F, Fibbe WE,. Mesenchymal stromal cells. Ann N Y Acad Sci 2009; 1176: 101-117.
82. Lindroos B, Suuronen R, Miettinen S,. The potential of adipose stem cells in regenerative medicine. Stem Cell Rev Rep 2011; 269-291.
83. Yoshimura K, Shigeura T, Matsumoto D, Sato T, Takaki Y, Aiba-Kojima E, etal. Characterization of freshly isolated and cultured cells derived from the fatty and fluid portions of liposuction aspirates. J Cell Physiol 2006; 208: 64-76.
84. Eto H, Suga H, Matsumoto D, Inoue K, Aoi N, Kato H, etal. Characterization of structure and cellular components of aspirated and excised adipose tissue. Plast Reconstr Surg 2009; 124: 1087-1097.
85. Casteilla L, Planat-Benard V, Laharrague P, Cousin B,. Adipose-derived stromal cells: their identity and uses in clinical trials, an update. World J Stem Cells 2011; 3: 25.
86. Yoshimura K, Sato K, Aoi N, Kurita M, Hirohi T, Harii K,. Cell-assisted lipotransfer for cosmetic breast augmentation: supportive use of adipose-derived stem/stromal cells. Aesthetic Plast Surg 2008; 32: 48-55.
87. Riordan NH, Ichim TE, Min W-P, Wang H, Solano F, Lara F, etal. Non-expanded adipose stromal vascular fraction cell therapy for multiple sclerosis. J Transl Med 2009; 7: 1-9.
88. Bai X, Yan Y, Song Y-H, Seidensticker M, Rabinovich B, Metzele R, etal. Both cultured and freshly isolated adipose tissue-derived stem cells enhance cardiac function after acute myocardial infarction. Eur Heart J 2010; 31: 489-501.
89. Garcia-Olmo D, Herreros D, Pascual M, Pascual I, De-La-Quintana P, Trebol J, etal. Treatment of enterocutaneous fistula in Crohn's disease with adipose-derived stem cells: a comparison of protocols with and without cell expansion. Int J Colorectal Dis 2009; 24: 27-30.
90. Gimble JM, Guilak F, Bunnell BA,. Clinical and preclinical translation of cell-based therapies using adipose tissue-derived cells. Stem Cell Res Ther 2010; 1: 19.
91. Gimble JM, Bunnell BA, Chiu ES, Guilak F,. Concise review: adipose-derived stromal vascular fraction cells and stem cells: let's not get lost in translation. Stem Cells 2011; 29: 749-754.
92. Gimble J, Guilak F,. Adipose-derived adult stem cells: isolation, characterization, and differentiation potential. Cytotherapy 2003; 5: 362-369.
93. Kern S, Eichler H, Stoeve J, Kluter H, Bieback K,. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 2006; 24: 1294-1301.
94. Yuan F, Lei YH, Fu XB, Sheng ZY, Cai S, Sun TZ,. Promotive effect of adipose-derived stem cells on the wound model of human epidermal keratinocytes in vitro. Wai Ke Za Zhi 2008; 46: 1575.
95. Park B-S, Jang KA, Sung J-H, Park J-S, Kwon YH, Kim KJ, etal. Adipose-derived stem cells and their secretory factors as a promising therapy for skin aging. Dermatol Surg 2008; 34: 1323-1326.
96. Van Brunt J, Klausner A,. Growth factors speed wound healing. Nat Biotechnol 1988; 6: 25-30.
97. Falanga V,. Growth Factors and Wound Healing. In, Roegnik RK, Roegnik HH, (eds.) New Trends in Dermatologic Surgery. London: Martin Dunitz, 1993: 47-54.
98. Cross KJ, Mustoe TA,. Growth factors in wound healing. Surg Clin North Am 2003; 83: 531.
99. Galiano RD, Tepper OM, Pelo CR, Bhatt KA, Callaghan M, Bastidas N, etal. Topical vascular endothelial growth factor accelerates diabetic wound healing through increased angiogenesis and by mobilizing and recruiting bone marrow-derived cells. Am J Pathol 2004; 164: 1935-1947.
100. Werner S, Grose R,. Regulation of wound healing by growth factors and cytokines. Physiol Rev 2003; 83: 835-870.
101. Quaglino D Jr, Nanney L, Ditesheim J, Davidson J,. Transforming growth factor-beta stimulates wound healing and modulates extracellular matrix gene expression in pig skin: incisional wound model. J Invest Dermatol 1991; 97: 34.
102. Greenhalgh D, Sprugel K, Murray M, Ross R,. PDGF and FGF stimulate wound healing in the genetically diabetic mouse. Am J Pathol 1990; 136: 1235.
103. Nambu M, Kishimoto S, Nakamura S, Mizuno H, Yanagibayashi S, Yamamoto N, etal. Accelerated wound healing in healing-impaired db/db mice by autologous adipose tissue-derived stromal cells combined with atelocollagen matrix. Ann Plast Surg 2009; 62: 317-321.
104. Altman AM, Yan Y, Matthias N, Bai X, Rios C, Mathur AB, etal. IFATS collection: human adipose-derived stem cells seeded on a silk fibroin-chitosan scaffold enhance wound repair in a murine soft tissue injury model. Stem Cells 2009; 27: 250-258.
105. Blanton MW, Hadad I, Johnstone BH, Mund JA, Rogers PI, Eppley BL, etal. Adipose stromal cells and platelet-rich plasma therapies synergistically increase revascularization during wound healing. Plast Reconstr Surg 2009; 123 (2 Suppl.): 56S-64S.
106. Kim WS, Park BS, Park SH, Kim HK, Sung JH,. Antiwrinkle effect of adipose-derived stem cell: activation of dermal fibroblast by secretory factors. J Dermatol Sci 2009; 53: 96-102.
107. Nambu M, Ishihara M, Nakamura S, Mizuno H, Yanagibayashi S, Kanatani Y, etal. Enhanced healing of mitomycin C-treated wounds in rats using inbred adipose tissue-derived stromal cells within an atelocollagen matrix. Wound Repair Regen 2007; 15: 505-510.
108. Lu F, Mizuno H, Uysal CA, Cai X, Ogawa R, Hyakusoku H,. Improved viability of random pattern skin flaps through the use of adipose-derived stem cells. Plast Reconstr Surg 2008; 121: 50-58.
109. Amos PJ, Kapur SK, Stapor PC, Shang H, Bekiranov S, Khurgel M, etal. Human adipose-derived stromal cells accelerate diabetic wound healing: impact of cell formulation and delivery. Tissue Eng Part A 2010; 16: 1595-1606.
110. Ebrahimian TG, Pouzoulet F, Squiban C, Buard V, André M, Cousin B, etal. Cell therapy based on adipose tissue-derived stromal cells promotes physiological and pathological wound healing. Arterioscler Thromb Vasc Biol 2009; 29: 503-510.
111. Uysal AC, Mizuno H, Tobita M, Ogawa R, Hyakusoku H,. The effect of adipose-derived stem cells on ischemia-reperfusion injury: immunohistochemical and ultrastructural evaluation. Plast Reconstr Surg 2009; 124: 804-815.
112. Di Rocco G, Gentile A, Antonini A, Ceradini F, Wu JC, Capogrossi MC, etal. (2011) Enhanced healing of diabetic wounds by topical administration of adipose tissue-derived stromal cells overexpressing stromal-derived factor-1: biodistribution and engraftment analysis by bioluminescent imaging. Stem Cells Int 2010 Dec 26: 304562.
113. Nie C, Yang D, Xu J, Si Z, Jin X, Zhang J,. Locally administered adipose-derived stem cells accelerate wound healing through differentiation and vasculogenesis. Cell Transplant 2011; 20: 205-216.
114. Lee SH, Lee JH, Cho KH,. Effects of human adipose-derived stem cells on cutaneous wound healing in nude mice. Ann Dermatol 2011; 23: 150-155.
115. Huang SP, Hsu CC, Chang SC, Wang CH, Deng SC, Dai NT, etal. Adipose-derived stem cells seeded on acellular dermal matrix grafts enhance wound healing in a murine model of a full-thickness defect. Ann Plast Surg 2012; 69: 656-662.
116. Song SH, Lee MO, Lee JS, Jeong HC, Kim HG, Kim WS, etal. Genetic modification of human adipose-derived stem cells for promoting wound healing. J Dermatol Sci 2012; 66: 98-107.
117. Nagai MK, Embil JM,. Becaplermin: recombinant platelet derived growth factor, a new treatment for healing diabetic foot ulcers. Expert Opin Biol Ther 2002; 2: 211-218.
118. Tsang MW, Wong WK, Hung CS, Lai KM, Tang W, Cheung EY, etal. Human epidermal growth factor enhances healing of diabetic foot ulcers. Diabetes Care 2003; 26: 1856-1861.
119. Wu Y, Chen L, Scott PG, Tredget EE,. Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. Stem Cells 2007; 25: 2648-2659.
120. Lee EY, Xia Y, Kim WS, Kim MH, Kim TH, Kim KJ, etal. Hypoxia-enhanced wound-healing function of adipose-derived stem cells: increase in stem cell proliferation and up-regulation of VEGF and bFGF. Wound Repair Regen 2009; 17: 540-547.
121. Trottier V, Marceau-Fortier G, Germain L, Vincent C, Fradette J,. IFATS collection: using human adipose-derived stem/stromal cells for the production of new skin substitutes. Stem Cells 2008; 26: 2713-2723.
122. Kim WS, Park BS, Sung JH,. The wound-healing and antioxidant effects of adipose-derived stem cells. Expert Opin Biol Ther 2009; 9: 879-887.
123. Buravkova LB, Grinakovskaia OS, Andreeva EP, Zhambalova AP, Kozionova MP,. [Characteristics of human lipoaspirate-isolated mesenchymal stromal cells cultivated under a lower oxygen tension]. Tsitologiia 2009; 51: 5-11.
124. Grayson WL, Zhao F, Bunnell B, Ma T,. Hypoxia enhances proliferation and tissue formation of human mesenchymal stem cells. Biochem Biophys Res Commun 2007; 358: 948-953.
125. Amos PJ, Bailey AM, Shang H, Katz AJ, Lawrence MB, Peirce SM,. Functional binding of human adipose-derived stromal cells: effects of extraction method and hypoxia pretreatment. Ann Plast Surg 2008; 60: 437-444.
126. Thangarajah H, Vial IN, Chang E, El-Ftesi S, Januszyk M, Chang EI, etal. IFATS collection: adipose stromal cells adopt a proangiogenic phenotype under the influence of hypoxia. Stem Cells 2009; 27: 266-274.
127. Rubina K, Kalinina N, Efimenko A, Lopatina T, Melikhova V, Tsokolaeva Z, etal. Adipose stromal cells stimulate angiogenesis via promoting progenitor cell differentiation, secretion of angiogenic factors, and enhancing vessel maturation. Tissue Eng Part A 2009; 15: 2039-2050.
128. Rubio D, Garcia-Castro J, Martin MC, de la Fuente R, Cigudosa JC, Lloyd AC, etal. Spontaneous human adult stem cell transformation. Cancer Res 2005; 65: 3035-3039.
129. Schreml S, Szeimies R-M, Prantl L, Landthaler M, Babilas P,. Wound healing in the 21st century. J Am Acad Dermatol 2010; 63: 866-881.
130. Butler KL, Goverman J, Ma H, Fischman A, Yu Y-M, Bilodeau M, etal. Stem cells and burns: review and therapeutic implications. J Burn Care Res 2010; 31: 874-881.
131. Falanga V,. Wound healing and its impairment in the diabetic foot. Lancet 2005; 366: 1736-1743.
132. Trengove NJ, Stacey MC, Macauley S, Bennett N, Gibson J, Burslem F, etal. Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors. Wound Repair Regen 1999; 7: 442-452.
133. Mast BA, Schultz GS,. Interactions of cytokines, growth factors, and proteases in acute and chronic wounds. Wound Repair Regen 1996; 4: 411-420.
134. Wiegand C, Schönfelder U, Abel M, Ruth P, Kaatz M, Hipler U-C,. Protease and pro-inflammatory cytokine concentrations are elevated in chronic compared to acute wounds and can be modulated by collagen type I in vitro. Arch Dermatol Res 2010; 302: 419-428.
135. Koenen P, Spanholtz TA, Maegele M, Stürmer E, Brockamp T, Neugebauer E, etal. Acute and chronic wound fluids inversely influence adipose-derived stem cell function: molecular insights into impaired wound healing. Int Wound J 2013 Mar 13 [Epub ahead of print].
136. Tarte K, Gaillard J, Lataillade J-J, Fouillard L, Becker M, Mossafa H, etal. Clinical-grade production of human mesenchymal stromal cells: occurrence of aneuploidy without transformation. Blood 2010; 115: 1549-1553.
137. Lendeckel S, Jödicke A, Christophis P, Heidinger K, Wolff J, Fraser JK, etal. Autologous stem cells (adipose) and fibrin glue used to treat widespread traumatic calvarial defects: case report. J Craniomaxillofac Surg 2004; 32: 370-373.
138. Menasche P,. Cell-based therapy for heart disease: a clinically oriented perspective. Mol Ther 2009; 17: 758-766.
139. Tateishi-Yuyama E, Matsubara H, Murohara T, Ikeda U, Shintani S, Masaki H, etal. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet 2002; 360: 427-435.
140. Matoba S, Tatsumi T, Murohara T, Imaizumi T, Katsuda Y, Ito M, etal. Long-term clinical outcome after intramuscular implantation of bone marrow mononuclear cells (Therapeutic Angiogenesis by Cell Transplantation [TACT] trial) in patients with chronic limb ischemia. Am Heart J 2008; 156: 1010-1018.
141. Mesimäki K, Lindroos B, TÅ'rnwall J, Mauno J, Lindqvist C, Kontio R, etal. Novel maxillary reconstruction with ectopic bone formation by GMP adipose stem cells. Int J Oral Maxillofac Surg 2009; 38: 201-209.
142. Le Blanc K, Ringdén O,. Immunomodulation by mesenchymal stem cells and clinical experience. J Intern Med 2007; 262: 509-525.
143. Constantin G, Marconi S, Rossi B, Angiari S, Calderan L, Anghileri E, etal. Adipose-derived mesenchymal stem cells ameliorate chronic experimental autoimmune encephalomyelitis. Stem Cells 2009; 27: 2624-2635.
144. Moustakas A, Heldin CH,. Signaling networks guiding epithelial- mesenchymal transitions during embryogenesis and cancer progression. Cancer Sci 2007; 98: 1512-1520.
145. Karnoub AE, Dash AB, Vo AP, Sullivan A, Brooks MW, Bell GW, etal. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 2007; 449: 557-563.
146. Dietrich J, Imitola J, Kesari S,. Mechanisms of disease: the role of stem cells in the biology and treatment of gliomas. Nat Clin Pract Oncol 2008; 5: 393-404.
147. Spaeth E, Klopp A, Dembinski J, Andreeff M, Marini F,. Inflammation and tumor microenvironments: defining the migratory itinerary of mesenchymal stem cells. Gene Ther 2008; 15: 730-738.
148. Andrae J, Gallini R, Betsholtz C,. Role of platelet-derived growth factors in physiology and medicine. Genes Dev 2008; 22: 1276-1312.
149. Walter M, Liang S, Ghosh S, Hornsby P, Li R,. Interleukin 6 secreted from adipose stromal cells promotes migration and invasion of breast cancer cells. Oncogene 2009; 28: 2745-2755.
150. Xu F, Gomillion C, Maxson S, Burg KJ,. In vitro interaction between mouse breast cancer cells and mouse mesenchymal stem cells during adipocyte differentiation. J Tissue Eng Regen Med 2009; 3: 338-347.
151. Sterodimas A, de Faria J, Nicaretta B, Papadopoulos O, Papalambros E, Illouz YG,. Cell-assisted lipotransfer. Aesthet Surg J 2010; 30: 78-81.